10-QPeriod: Q2 FY2016

INTUITIVE SURGICAL INC Quarterly Report for Q2 Ended Jun 30, 2016

Filed July 20, 2016For Securities:ISRG

Summary

Intuitive Surgical Inc. (ISRG) reported strong financial performance for the six months ending June 30, 2016, demonstrating robust revenue growth and increasing profitability. Total revenue grew by 14% year-over-year for the second quarter, reaching $670.1 million, with a consistent 70% of that revenue coming from recurring sources like instruments, accessories, and service. This highlights the company's successful business model which benefits from both capital equipment sales and ongoing revenue streams tied to system usage. The company also saw significant growth in procedure volume, up 16% for the second quarter, indicating increasing adoption of the da Vinci Surgical System. This procedure growth is a key driver for recurring revenue and demonstrates the expanding market penetration of their innovative surgical technology. With a solid cash position and strong operational cash flow, Intuitive Surgical appears well-positioned for continued growth and investment in research and development.

Financial Highlights

45 data points
Beta

Revenue

$670.10M

70.3% Gross Margin

Net Income

$184.50M

27.5% Net Margin

EPS (Diluted)

$0.52

Total Assets

$5.78B

Cash & Equivalents

$1.19B

Free Cash Flow

$261.70M

Financial Statements
Beta
Revenue$670.10M
Cost of Revenue$199.20M
Gross Profit$470.90M
R&D Expenses$54.70M
SG&A Expenses$170.80M
Operating Expenses$225.50M
Operating Income$245.40M
Net Income$184.50M
EPS (Basic)$0.54
EPS (Diluted)$0.52
Shares Outstanding (Basic)344.70M
Shares Outstanding (Diluted)352.80M

Key Highlights

  • 1Total revenue increased by 14% to $670.1 million for the three months ended June 30, 2016, compared to $586.1 million in the prior year period.
  • 2Recurring revenue, comprising instruments, accessories, and service, grew by 14% to $467.4 million, maintaining its significant contribution at 70% of total revenue.
  • 3Da Vinci procedures performed increased by approximately 16% year-over-year for the second quarter, reaching approximately 188,000 procedures.
  • 4Systems revenue saw a 15% increase to $202.7 million, driven by higher system shipments and an increase in average selling price due to a favorable product mix.
  • 5Gross profit margin improved to 70.3% for the second quarter of 2016, up from 65.9% in the same period of 2015, primarily due to manufacturing efficiencies and cost reductions.
  • 6Operating income increased significantly by 41% to $245.4 million, demonstrating strong operational leverage.
  • 7The company's cash, cash equivalents, and investments grew to $4.2 billion as of June 30, 2016, indicating a healthy financial position.

Frequently Asked Questions

Intuitive Surgical's revenue growth is primarily driven by a combination of increased da Vinci Surgical System shipments and a substantial increase in recurring revenue from instruments, accessories, and service. The growing number of procedures performed using their systems directly fuels the demand for these recurring revenue streams.

The company demonstrated strong performance in the second quarter of 2016. Total revenue increased by 14%, operating income rose by 41%, and gross profit margin improved significantly. This growth was supported by a 16% increase in da Vinci procedures and a 15% rise in systems revenue.

Recurring revenue is crucial for Intuitive Surgical as it consistently represents about 70% of their total revenue. This segment, generated from the sale of instruments, accessories, and service contracts, provides a stable and growing income stream that is less dependent on large capital equipment sales, demonstrating strong customer engagement and system utilization.

The company is involved in various legal proceedings, including product liability lawsuits and shareholder class actions. While the company has recorded charges for estimated losses in some product liability cases, it currently does not believe the resolution of these matters will have a material adverse effect on its business, financial position, or future results of operations, though this remains a potential risk.